Ascorbic acid may help to manageanemia in hemodialysis (HD) patients,according to a study.&

Romanian researchers randomized69 HD patients with anemiato receive, for 12 months, 300 mgintravenous ascorbic acid 3 times aweek, or placebo. 

After the first 3 months, theascorbic acid group had a significantlygreater rise in hemoglobincompared with the control group.Doses of erythropoiesis-stimulatingagent decreased significantly after 6months only in the intervention arm,but remained stable in the controlgroup. Serum ferritin increased onlyin patients on ascorbic acid and onlyafter 6 months. Iron requirementsdecreased significantly only in theintervention group.

Continue Reading